Free Access
Free Access to the whole issue
Veterinary Research
Volume 31 / No 1 (January-February 2000)
Free Access
Biochemical and molecular analysis of structural proteins of porcine reproductive and respiratory syndrome virus p. 22
Free Access
PRRSV-macrophage interaction and putative receptors p. 22
Free Access
Expression of a foreign epitope by porcine reproductive and respiratory syndrome virus p. 23
Free Access
Structure-function of the nucleocapsid protein of PRRSV North American genotype p. 24
Free Access
A review of evidence for immunosuppression due to Porcine Reproductive and Respiratory Syndrome Virus p. 27
Free Access
Pig defences against respiratory viruses p. 40
Free Access
Characteristics of the immune response of pigs to PRRS virus p. 41
Free Access
New strategies in the development of PRRS vaccines. Subunit vaccines and self-limiting vectors, based on defective coronaviruses p. 41
Free Access
Phenotypical and functional analysis of macrophages infected with PRRS virus p. 42
Free Access
Passive immunity due to PRRS in vaccinated and unvaccinated sow herds p. 44
Free Access
Direct cytolytic activity of pbmc from pigs infected with porcine reproductive and respiratory syndrome p. 44
Free Access
Ultrastructural pathogenesis of the PRRS virus p. 47
Free Access
Pathogenesis of porcine reproductive and respiratory syndrome virus (PRRSV) in gestating sows p. 56
Free Access
The pathogenesis of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) in the boar p. 57
Free Access
PRRSV: Study of in vivo cell tropism and virus-induced apoptosis by in situ detection techniques p. 58
Free Access
Virulence of vABV 414, the virus derived from the infectious cDNA clone of the Lelystad virus, for third trimester pregnant gilts p. 59
Free Access
Effect of vaccination on dual infection with Mycoplasma hyopneumoniae and PRRSV p. 60
Free Access
A brief review of procedures and potential problems associated with the diagnosis of porcine reproductive and respiratory syndrome p. 61
Free Access
Diagnosing acute infections of porcine reproductive and respiratory syndrome virus in swine p. 70
Free Access
Diagnosis of persistent or prolonged porcine reproductive and respiratory syndrome virus infections p. 71
Free Access
Distinction between infections with European and American/vaccine type PRRS virus after vaccination with a modified-live PRRS virus vaccine p. 72
Free Access
Detection of antibodies to porcine reproductive and respiratory syndrome virus (PRRSV) in blended sera or in blood samples collected on filter papers p. 73
Free Access
Monitoring of PRRSV infection status in swine herds based on analysis of antibodies in meat sample drippings p. 74
Free Access
Development of a serological marker system for epidemiological studies of porcine reproductive and respiratory syndrome virus p. 74
Free Access
The "colorful" epidemiology of PRRS p. 77
Free Access
PRRS in North America, Latin America, and Asia p. 84
Free Access
Seroepidemiology of porcine reproductive and respiratory syndrome virus infection on commercial farms p. 85
Free Access
History, occurrence, dynamics and current status of PRRS in Europe p. 86
Free Access
Prevalence and risk factors for infection with Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) in swine herds in Illinois (USA) p. 87
Free Access
A longitudinal study into the interaction between PRRSV and Mycoplasma hyopneumoniae in finishing pigs p. 88
Free Access
Genetic variations among PRRSV strains isolated in Italy and in Russia p. 89
Free Access
Experiences with eradication of Porcine Reproductive and Respiratory Syndrome in Danish swine herds p. 91
Free Access
Control of Porcine Reproductive and Respiratory Syndrome: the challenge of identifying carrier animals p. 91
Free Access
Vaccinology of PRRS p. 92
Free Access
Elimination of PRRS virus in five pig farms using a test and removal procedure in the breeding herd p. 93
Free Access
Eradication of Porcine Reproductive and Respiratory Syndrome virus in 125 herds in “Pays de la Loire" (France) p. 94
Free Access
The production of PRRS negative pigs from multiple PRRS serologically stable herds over time using segregated early weaning (SEW) p. 95
Free Access
Vaccination of MDA positive pigs with a live modified PRRSV vaccine p. 96
Free Access
Efficacy of an American and a European serotype PRRSV vaccine after challenge with American and European wild–type strains of the virus p. 97
Free Access
Aujeszky's disease (pseudorabies) virus: the virus and molecular pathogenesis - State of the art, June 1999 p. 99
Free Access
Searching for genes of Aujeszky's disease virus required for neurotropism and virulence p. 116
Free Access
Functions of viral glycoproteins in the pathogenesis of Aujeszky's disease virus in pigs p. 116
Free Access
Latency of Aujeszky's disease virus p. 117
Free Access
Experimental infection of wild boar with pseudorabies virus isolates of different virulence p. 118
Free Access
Development and evaluation of TaqMan-based PCR assays to quantitate PRV latency p. 119
Free Access
Aujeszky's disease virus: opportunities and challenges p. 121
Free Access
DNA vaccine coding for glycoprotein B of PRV induces cytotoxic T cell responses in pigs against PRV p. 132
Free Access
Mechanisms of protective immunity against Aujeszky's disease virus p. 132
Free Access
Effects of cytokines upon the immune response of swine to Aujeszky's disease virus p. 133
Free Access
Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus p. 134
Free Access
Genetically improved Aujeszky's disease strain MNC+/10a derived from strain K/61 and testing for safety and potency in pigs p. 135
Free Access
Analysis of protective immunity against PRV infection in pigs using attenuated and inactivated PRV vaccines p. 135
Free Access
Antibody-induced endocytosis of viral glycoproteins, expressed on pseudorabies virus-infected monocytes protects these cells from complement-mediated lysis p. 136
Free Access
Phenotype of IL-2 or pseudorabies virus induced cytolytic cells in the pig p. 137
Free Access
Increased immunogenicity of a DNA vaccine encoding pseudorabies virus IE180 protein by co-administration of IL-2 or by delivery in liposomes p. 138
Free Access
Challenges of the final stages of the ADV eradication program p. 141
Free Access
Risk factors of new Aujeszky's disease virus infection in swine herds in Brittany (France) p. 146
Free Access
Non-vaccinated subpopulations play a major role in reinfections during eradication programs based on regular vaccination against Aujeszky's disease virus p. 147
Free Access
Aujeszky's disease virus (ADV) in mammalian wildlife on swine farms in Illinois (USA): Potential for transmission to non-infected herds p. 148
Free Access
Spatial-temporal dynamics of pseudorabies virus infections in a wild boar population p. 149
Free Access
Modelling pseudorabies virus infection supports eradication p. 149
Free Access
Development of a computerised system for animal health management as a part of an eradication program of Aujeszky's disease p. 150
Free Access
Progress in eradication and control programmes against Aujeszky's disease (pseudorabies) in France p. 151
Free Access
The eradication of Aujeszky's disease from pig production in Sweden p. 152
Free Access
No Aujeszky's disease or PRRS in Finland p. 153
Free Access
Evaluation of Italian Aujeszky's disease control programme in two regions of northern Italy in 1997 p. 154
Free Access
Progress of the Aujeszky's disease virus eradication programme in Brittany (France) p. 155
Free Access
Current epizootiological status of the Eastern European countries for Aujeszky's disease p. 155
Free Access
The results of serological monitoring for Aujeszky's disease in pigs performed during the period of 1991-1997 p. 156
Free Access
The eradication of Aujeszky's disease in the United States p. 157
Free Access
Update of the Aujeszky's disease situation in Argentina p. 158
Free Access
Effectiveness and costs of different strategies to eradicate Aujeszky's disease virus p. 158
Free Access
Aujeszky's disease: the position of the European Commission and regulation perspectives p. 159
Free Access
Terminating Aujeszky vaccination in the Netherlands? p. 160
Free Access